Premium
Oncocyte Corporation (OCX)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers.... OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through the United States, and it earns revenue from the sale of diagnostic tests. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.1959 | 7.55175205274 | 2.5941 | 2.8 | 2.21 | 125230 | 2.52417903 | CS |
| 4 | 0.72 | 34.7826086957 | 2.07 | 2.8 | 1.922 | 90584 | 2.2690351 | CS |
| 12 | 0.29 | 11.6 | 2.5 | 2.8 | 1.922 | 97083 | 2.30907148 | CS |
| 26 | -0.23 | -7.61589403974 | 3.02 | 3.34 | 1.922 | 62518 | 2.50999117 | CS |
| 52 | -0.19 | -6.37583892617 | 2.98 | 3.4799 | 1.922 | 55588 | 2.65899439 | CS |
| 156 | -25.41 | -90.1063829787 | 28.2 | 33.6 | 1.922 | 218477 | 12.91289622 | CS |
| 260 | -67.01 | -96.0028653295 | 69.8 | 125 | 1.922 | 302121 | 43.19262943 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
